Development of novel microarray methodology for the study of mutations in the SERPINA1 and ADRB2 genes-Their association with Obstructive Pulmonary Disease and Disseminated Bronchiectasis in Greek patients

Clinical Biochemistry

Volumn 43, Issue 1-2, 2010, Pages 43-50

  Papatheodorou, Athanasios ^a   Makrythanasis, Periklis ^a,b   Kaliakatsos, Marios ^a   Dimakou, Aikaterini ^c   Orfanidou, Dora ^a   Roussos, Charis ^d   Kanavakis, Emmanuel ^a   Tzetis, Maria ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c Sotiria Chest Diseases Hospital   (Greece)

^d Evangelismos Hospital   (Greece)

Author keywords

Chronic Obstructive Pulmonary Disease; Disseminated Bronchiectasis; haplotypes; SERPINA1 ADRB2; SNPs

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR A1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRONCHIECTASIS; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GREECE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NANOCHIP; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN; BRONCHIECTASIS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS;

EID: 72649086455     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.08.026     Document Type: Article

References (33)

1. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163 (2001) 1256-1276
2. Sandford A.J., and Silverman E.K. Chronic obstructive pulmonary disease: 1. Susceptibility factors for COPD the genotype-environment interaction. Thorax 57 (2002) 736-741
3. Joos L., Pare P.D., and Sandford A.J. Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med. Wkly. 132 (2002) 27-37
4. Luisetti M., Gile L.S., Bombieri C., Benetazzo M.G., and Pignatti P.F. Genetics of chronic obstructive pulmonary disease and disseminated bronchiectasis. Monaldi Arch. Chest Dis. 53 (1998) 614-616
5. Dagli E. Non cystic fibrosis bronchiectasis. Paediatr. Respir. Rev. 1 (2000) 64-70
6. King P., Holdsworth S., Freezer N., and Holmes P. Bronchiectasis Internal Med. J. 36 (2006) 729-737
7. Cichy J., Rose-John S., Travis J., and Oncostatin M. Leukaemia-inhibitory factor and interleukin 6 trigger different effects on α1-proteinase inhibitor synthesis in human lung-derived epithelial cells. Biochem. J. 329 (1998) 335-339
8. Crystal R.G. Alpha-1-antitrypsin deficiency, emphysema, and liver disease-genetic basis and strategies for therapy. J. Clin. Invest. 85 (1990) 1343-1352
9. Fergonese L., and Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J. Rare Dis. 3 (2008) 16-25
10. Greene C.M., Miller S.D.W., Carroll T., McLean C., O'Mahony M., Lawless M.W., et al. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations. J. Inherit. Metab. Dis. 31 (2008) 21-34
11. Kohnlein T., and Welte T. Alpha-1-antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis and treatment. Am. J. Med. 121 (2008) 3-9
12. Chapell S., Daly L., Morgan K., Baranes T.G., Roca J., Rabinovich R., et al. Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum. Mutat. 27 (2006) 103-109
13. Hersh C.P., Dahl M., Ly N.P., Berkey C.S., Nordestgaard B.G., and Silverman E.K. Chronic obstructive pulmonary disease in alpha 1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 59 (2004) 843-849
14. DeMeo D.L., and Silverman E.K. a1-Antitrypsin deficiency 2: genetic aspects of a1- antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 59 (2004) 259-264
15. Morgan K., and Kalsheker N.A. Regulation of the serine proteinase inhibitor (SERPIN) gene alpha 1-antitrypsin: a paradigm for other SERPINs. Int. J. Biochem. Cell Biol. 29 (1997) 1501-1511
16. Drysdale C.M., McGraw D.W., Stack C.B., Stephens J.C., et al. Complex promoter and coding region beta2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10483-10488
17. Green S.A., Cole G., Jacinto M., Innis M., and Liggett S.B. A polymorphism of the human beta2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268 (1993) 23116-23121
18. Green S.A., Turki J., Bejarano P., Hall I.P., and Liggett S.B. Influence of beta2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13 (1995) 25-33
19. 2-adrenoceptor in COPD in Chinese subjects. Chest 120 (2001) 1493-1499
20. Papatheodorou A., Latsi P., Vrettou C., Dimakou A., Chroneou A., Makrythanasis P., et al. Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-alpha gene: their association with obstructive pulmonary disease in Greek patients. Clin. Biochem. 40 (2007) 843-850
21. Hayes V.M. Genetic diversity of the alpha-1-antitrypsin gene in Africans identified using a novel genotyping assay. Hum. Mutat. 22 (2003) 59-66
22. Turki J., Pak J., Green S.A., et al. Genetic polymorphisms of the b2-adrenergic receptor in nocturnal and non-nocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J. Clin. Invest. 95 (1995) 1635-1641
23. Weir T.D., Mallek N., Sandford A.J., et al. b2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am. J. Respir. Crit. Care Med. 158 (1998) 787-791
24. Hall I.P., Wheatley A., Wilding P., et al. Association of Glu 27 b2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345 (1995) 1213-1214
25. Ramsay C.E., Hayden C.M., Tiller K.J., et al. Polymorphisms in the b2-adrenoreceptor gene are associated with decreased airway responsiveness. Clin. Exp. Allergy 29 (1999) 1195-1203
26. Ulbrecht M., Hergeth M.T., Wjst M., et al. Association of b2-adrenoreceptor variants with bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 161 (2000) 469-474
27. D'Amato M., Vitiani L.R., Petrelli G., et al. Association of persistent bronchial hyperresponsiveness with b2-adrenoceptor (ADRB2) haplotypes: a population study. Am. J. Respir. Crit. Care Med. 158 (1998) 1968-1973
28. Summerhill E., Leavitt S.A., Gidley H., et al. b2-Adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites. Am. J. Respir. Crit. Care Med. 162 (2000) 599-602
29. Wang Z., Chen C., Niu T., et al. Association of asthma with b2-adrenergic receptor gene polymorphism and cigarette smoking. Am. J. Respir. Crit. Care Med. 163 (2001) 1404-1409
30. Green S.A., Turki J., Innis M., et al. Amino-terminal polymorphisms of the human b2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33 (1994) 9414-9419
31. Martinez F.D., Graves P.E., Baldini M., et al. Association between genetic polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J. Clin. Invest. 100 (1997) 3184-3188
32. Hegab A.E., Sakamoto T., Saitoh W., Massoud H.H., Massoud H.M., Hassanein K.M., et al. Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest 126 6 (2004) 1832-1839
33. 2-Adrenoceptor polymorphisms: are they clinically important?. Thorax 51 (1996) 351-353